Botanical ingredients bring valuable formulation possibilities to dietary supplements—but their natural variability also makes identity verification a foundational manufacturing control. A supplier certificate of analysis (COA) can be useful evidence, yet it is not a substitute for a documented, ingredient-appropriate verification program.
This article outlines a practical way to connect botanical identity specifications, receiving controls, laboratory methods, and quality-unit decisions. It is intended as a manufacturing discussion, not legal advice.
Why botanical identity needs a deliberate plan
Common names can overlap. Plant part, geographic origin, harvest conditions, processing, extraction, and particle size can all change what a material looks like and how it behaves in an examination. The manufacturing question is not simply whether paperwork arrived with the shipment; it is whether the material can be shown to meet its established identity specification before use.
For dietary supplements, 21 CFR Part 111 requires specifications for components and requires at least one appropriate test or examination to verify the identity of each dietary ingredient before use, unless FDA grants a petitioned alternative. FDA explains that the appropriate method is ingredient-specific; one method may be sufficient in some cases, while more than one may be needed in others.
Start with an identity specification that matches the material
An effective specification translates the purchasing description into attributes a quality team can assess. Depending on the material, a specification may address:
- Accepted botanical name and the intended plant part
- Form: whole, cut, powdered, standardized extract, or another defined preparation
- Supplier, origin, lot traceability, and storage conditions
- Reference standard or authenticated comparative material where appropriate
- Method suitability, acceptance criteria, and who reviews the outcome
That detail matters because a sensory check that may help with a whole or coarsely cut botanical does not automatically provide the same assurance for a powder or extract. The method should be scientifically appropriate to the form, known risks, and specification.
Build a receiving workflow that preserves evidence
1. Link the lot to the purchase and supplier records
At receiving, reconcile the shipment, container condition, lot identifiers, and accompanying documents. Keep the supplier COA as part of the record—not as the sole identity decision.
2. Take representative samples under controlled procedures
Sampling should follow written procedures that protect the sample’s representativeness and traceability. The lot should remain controlled until quality has completed its review and disposition.
3. Choose an appropriate examination or test
FDA’s small-entity compliance guide lists examples such as organoleptic, macroscopic, microscopic, chemical, and other scientifically valid methods. A program may use one or a combination of these approaches when justified for the material. The key is a documented rationale, not a one-size-fits-all technique.
4. Record the decision, not just the result
Capture the method, reference materials, observations or instrument output, acceptance decision, reviewer, and any investigation. This turns a test result into a traceable quality decision.
Supplier qualification and testing work together
Supplier qualification can strengthen confidence in a botanical supply chain through defined agreements, change notifications, traceability expectations, and periodic performance review. It does not remove the need to meet applicable component specifications or the identity-verification requirement. A resilient system combines supplier evidence with receiving controls and a right-sized identity method.
Plan for the form you will actually manufacture
Identity risk can change after processing. A whole leaf, a fine powder, and a concentrated extract may need different evidence packages. During formulation and technical transfer, quality and R&D teams can align the component specification with the form, dosage format, and master manufacturing record. For broader manufacturing context, explore Reaps Pharma’s dietary supplement manufacturing services and private-label manufacturing approach.
A compact checklist for quality teams
- Define the botanical name, plant part, and material form.
- Establish written identity and other component specifications.
- Qualify suppliers and retain lot-level documentation.
- Select and justify an appropriate identity examination or test.
- Control sampling, quarantine, review, and disposition.
- Escalate discrepancies through documented quality procedures.
Frequently asked questions
Can a supplier COA replace identity verification?
A supplier COA may support decisions for applicable specifications, but FDA’s dietary-supplement CGMP framework calls for at least one appropriate identity test or examination for each dietary ingredient before use unless FDA grants an alternative by petition.
Is there one best identity method for every botanical?
No. Method selection should match the material’s form and the established specification. A documented, scientifically appropriate rationale is essential.
What should happen when a result does not meet the specification?
The lot should remain under the manufacturer’s quality controls while the discrepancy is investigated and dispositioned according to written procedures.
Bring identity evidence into the manufacturing conversation
Early alignment between brand, sourcing, R&D, and quality teams can help avoid late-stage surprises. Contact Reaps Pharma to discuss a manufacturing program with clear component expectations, documentation, and quality handoffs.
Sources: 21 CFR Part 111; FDA Small Entity Compliance Guide for Dietary Supplement CGMPs (accessed August 14, 2026).